Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 149

Results For "IMA"

3524 News Found

Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows achieved groundbreaking results in liver disease due to MASH
Clinical Trials | February 28, 2024

Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows achieved groundbreaking results in liver disease due to MASH

Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis


Ministry of Ayush signed MoU with Research and Information System for Developing Countries
Policy | February 28, 2024

Ministry of Ayush signed MoU with Research and Information System for Developing Countries

Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon


Ministry of Ayush and Ministry of Women and Child Development join hands for Nutritional Improvement in adolescent girls through Ayurveda interventions
News | February 27, 2024

Ministry of Ayush and Ministry of Women and Child Development join hands for Nutritional Improvement in adolescent girls through Ayurveda interventions

Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions


Zydus receives WHO prequalification for Miltefosine formulation and API
Drug Approval | February 26, 2024

Zydus receives WHO prequalification for Miltefosine formulation and API

Leishmaniasis is caused by protozoan parasites which are transmitted by the bite of infected female phlebotomine sandflies


Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India
News | February 24, 2024

Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India

Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully


VP Dhankhar emphasizes need for ethical standards in the medical profession at APICON-2024
News | February 24, 2024

VP Dhankhar emphasizes need for ethical standards in the medical profession at APICON-2024

The Vice President also highlighted the importance of preventive healthcare and fitness


AstraZeneca completes acquisition of Gracell
News | February 23, 2024

AstraZeneca completes acquisition of Gracell

The acquisition enriches AstraZeneca’s growing pipeline of cell therapies with GC012F


Aptar Digital Health acquires Healint to broaden neurology portfolio
News | February 23, 2024

Aptar Digital Health acquires Healint to broaden neurology portfolio

The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment


Moderna posts Q4 2023 revenue at US$ 2.8 billion
News | February 23, 2024

Moderna posts Q4 2023 revenue at US$ 2.8 billion

Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance


Pfizer and AIF’s Project Parivartan demonstrates progress in addressing antimicrobial resistance
News | February 22, 2024

Pfizer and AIF’s Project Parivartan demonstrates progress in addressing antimicrobial resistance

Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms